rs1553863660
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_003722.5(TP63):c.1799G>A(p.Gly600Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G600V) has been classified as Pathogenic.
Frequency
Consequence
NM_003722.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TP63 | NM_003722.5 | c.1799G>A | p.Gly600Asp | missense_variant | 14/14 | ENST00000264731.8 | NP_003713.3 | |
TP63 | NM_001114980.2 | c.1517G>A | p.Gly506Asp | missense_variant | 12/12 | ENST00000354600.10 | NP_001108452.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TP63 | ENST00000264731.8 | c.1799G>A | p.Gly600Asp | missense_variant | 14/14 | 1 | NM_003722.5 | ENSP00000264731.3 | ||
TP63 | ENST00000354600.10 | c.1517G>A | p.Gly506Asp | missense_variant | 12/12 | 1 | NM_001114980.2 | ENSP00000346614.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
TP63-Related Spectrum Disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2020 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed in individual(s) with clinical features of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (PMID: 22329826, 20491771, 16190990, Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as G506D and p.Gly561Asp. ClinVar contains an entry for this variant (Variation ID: 544362). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with aspartic acid at codon 600 of the TP63 protein (p.Gly600Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at